-+ 0.00%
-+ 0.00%
-+ 0.00%

3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks

Simply Wall St·07/14/2026 20:28:57
语音播报

With inflation, energy shocks and shifting interest rate expectations all pulling markets in different directions, many investors are looking for growth stories that management itself is confident enough to own. That is exactly what the Fast Growing Stocks With High Insider Ownership screener is built to highlight by filtering for companies where analysts see solid growth potential and insiders have committed their own capital. This combination can help you focus on businesses where outlook and ownership are aligned. In this article, you will see 3 of the best stocks from this screener that stand out for further research.

Predictive Discovery (ASX:PDI)

Overview: Predictive Discovery is a West Africa focused gold company whose primary asset is the Bankan Gold project in north east Guinea, supported by production from the Kiniero and Nampala mines after its merger with Robex. The company aims to turn a 9.5 million ounce resource and 4.5 million ounces of reserves into a multi mine production platform.

Market Cap: A$3.3b

Predictive Discovery provides exposure to a growing West African gold producer where recent updates show strong plant performance at Kiniero and Nampala, including higher throughput and 90.5% recovery. The large Bankan project remains the key long term opportunity. Analysts are incorporating very strong revenue and earnings growth expectations off a pre revenue base. Combined with the company trading well below Simply Wall St’s DCF estimate, this frames a valuation story that some investors will find compelling. At the same time, a short cash runway, heavy reliance on external funding, concentrated West African risk and recent insider selling indicate that the margin for error appears tight. That mix of potential upside and execution risk is what may make Predictive Discovery worth a closer look for some investors.

Predictive Discovery’s mix of a large West African gold resource, strong recent plant performance and a valuation gap to Simply Wall St’s DCF estimate could be masking a crucial twist in the growth story that only shows up in the DCF valuation analysis for Predictive Discovery

PDI Discounted Cash Flow as at Jul 2026
PDI Discounted Cash Flow as at Jul 2026

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals develops and sells radiopharmaceutical products that help doctors both detect and treat cancers, using targeted imaging agents and therapies for conditions such as prostate cancer, kidney cancer and glioblastoma. The company combines commercial products like Illuccix and Gozellix with a broad late stage pipeline and in house manufacturing capabilities across several regions.

Operations: Telix Pharmaceuticals generates most of its revenue from Precision Medicine at about US$621.9m, with additional contributions from Manufacturing Solutions at about US$245.1m and Therapeutics at about US$9.3m, adjusted for inter segment eliminations.

Market Cap: A$5.4b

Telix Pharmaceuticals sits at the intersection of growing radiopharmaceutical demand and a maturing product suite, with Illuccix and Gozellix already supporting hundreds of millions of dollars in revenue while late stage trials like ProstACT Global and IPAX BrIGHT aim to extend its reach from imaging into therapy. The stock has seen a sharp share price pullback, and Telix is still loss making, with rising R&D, manufacturing build out costs and an SEC subpoena adding real execution risk. Analysts currently expect revenue growth that is higher than the broader market and see a potential path to profitability in the next few years, as well as a sizeable gap between current pricing and some published fair value estimates. Investors may wish to consider whether today’s combination of strong assets and unresolved issues represents a temporary setback or a longer term warning sign.

Telix Pharmaceuticals appears to be a growth story that has been temporarily stalled by cost pressure and regulatory overhangs, and the real question is how that tension resolves in the analyst forecasts for Telix Pharmaceuticals

ASX:TLX Earnings & Revenue Growth as at Jul 2026
ASX:TLX Earnings & Revenue Growth as at Jul 2026

Lindian Resources (ASX:LIN)

Overview: Lindian Resources is a Perth based explorer focused on rare earths, bauxite and gold across Tanzania, Guinea, Malawi, Australia and Singapore, with its flagship Kangankunde Rare Earths project in Malawi positioning the company in a critical minerals supply chain.

Market Cap: A$1.4b

Lindian Resources is drawing attention because Kangankunde has moved from concept to active mining, with first blasting complete and first production targeted for Q4 2026. Earnings and revenue are forecast to grow at very high rates and the business is expected to move into profitability within 3 years. At the same time, Lindian is still loss making, has relied entirely on higher risk external funding, has seen substantial shareholder dilution and carries governance concerns including a board with no independent directors and limited experience. If the fully funded project ramp up and new Singapore marketing hub translate into sustainable cash flows, the current mix of rapid progress and elevated risk could look very different to investors who wait on the sidelines.

Lindian Resources appears to be at a point where rapid progress is colliding with elevated funding and governance risk, and the missing piece is how those trade offs line up in the 1 key reward and 2 important warning signs (2 are major!)

ASX:LIN Earnings & Revenue Growth as at Jul 2026
ASX:LIN Earnings & Revenue Growth as at Jul 2026

The three stocks covered here are just a starting point, and the full Fast Growing Stocks With High Insider Ownership screen uncovers 98 more companies with equally compelling growth and insider ownership stories in the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter most to you so you can focus on the highest conviction ideas in this group.

Take Control of Your Investment Journey

If Predictive Discovery or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Markets move fast, and the most interesting ideas rarely stay under the radar for long. Scan these fresh stock groups before momentum runs away from you and consider them while they are still emerging.

  • Spot potential turnaround stories with strong balance sheets by scanning the curated list of solid balance sheet and fundamentals (20 results) while these companies are still flying under most investors’ radars, and review them before sentiment shifts.
  • Explore structural themes in critical materials by reviewing the hand picked 30 best rare earth metal stocks while demand narratives still matter more than crowded positioning, and assess them before the crowd reacts.
  • Evaluate potential income-oriented candidates by checking the carefully filtered 6 dividend fortresses while yields remain elevated and prices have not fully caught every payout focused investor’s attention, then decide if they fit your plan.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.